IS4615A - Mótefnavakar Helicobacter pylori og bóluefnablöndur - Google Patents

Mótefnavakar Helicobacter pylori og bóluefnablöndur

Info

Publication number
IS4615A
IS4615A IS4615A IS4615A IS4615A IS 4615 A IS4615 A IS 4615A IS 4615 A IS4615 A IS 4615A IS 4615 A IS4615 A IS 4615A IS 4615 A IS4615 A IS 4615A
Authority
IS
Iceland
Prior art keywords
helicobacter pylori
vaccine preparations
antigen
antigen helicobacter
vaccine
Prior art date
Application number
IS4615A
Other languages
English (en)
Inventor
Bölin Ingrid
Svennerholm Ann-Mari
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9502007A external-priority patent/SE9502007D0/xx
Priority claimed from SE9601085A external-priority patent/SE9601085D0/xx
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of IS4615A publication Critical patent/IS4615A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IS4615A 1995-06-01 1997-11-17 Mótefnavakar Helicobacter pylori og bóluefnablöndur IS4615A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9502007A SE9502007D0 (sv) 1995-06-01 1995-06-01 Novel polypeptides
SE9601085A SE9601085D0 (sv) 1996-03-21 1996-03-21 Novel polypeptides
PCT/SE1996/000727 WO1996038475A1 (en) 1995-06-01 1996-06-03 Helicobacter pylori antigens and vaccine compositions

Publications (1)

Publication Number Publication Date
IS4615A true IS4615A (is) 1997-11-17

Family

ID=26662316

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4615A IS4615A (is) 1995-06-01 1997-11-17 Mótefnavakar Helicobacter pylori og bóluefnablöndur

Country Status (22)

Country Link
US (2) US6025164A (is)
EP (1) EP0828757A1 (is)
JP (1) JP3380559B2 (is)
KR (1) KR19990022131A (is)
CN (1) CN1191544A (is)
AR (1) AR003125A1 (is)
BR (1) BR9608627A (is)
CA (1) CA2222797A1 (is)
CZ (1) CZ357397A3 (is)
EE (1) EE9700306A (is)
HU (1) HUP9901546A3 (is)
IL (1) IL122340A0 (is)
IS (1) IS4615A (is)
MY (1) MY119003A (is)
NO (1) NO975490L (is)
NZ (1) NZ303356A (is)
PL (1) PL323741A1 (is)
RU (1) RU2195463C2 (is)
SK (1) SK155297A3 (is)
TR (1) TR199701471T1 (is)
TW (1) TW570925B (is)
WO (1) WO1996038475A1 (is)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2682122B1 (fr) * 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
US6258359B1 (en) 1993-05-19 2001-07-10 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
JPH08509873A (ja) 1993-05-19 1996-10-22 アンスティテュ・パストゥール ヘリコバクター感染に対する免疫組成物、該組成物に用いられるポリペプチドおよび該ポリペプチドをコードする核酸配列
US6406703B1 (en) 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
EP0716613B1 (en) * 1993-07-27 2003-07-09 Csl Limited Treatment of helicobacter associated gastroduodenal disease
AUPM612494A0 (en) * 1994-06-08 1994-06-30 Csl Limited Treatment or prevention of helicobacter infection
HUP9900766A3 (en) * 1995-06-07 2002-08-28 Astra Ab Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
AU6584298A (en) * 1997-03-26 1998-10-20 Avant Immunotherapeutics, Inc. Carbohydrate antigens which immunoreact with polyclonal antisera against (h. pylori)
JP2002512619A (ja) * 1997-04-30 2002-04-23 メリウクス オラバクス 横隔膜下からの全身経路に使用するための抗ヘリコバクターワクチン組成物、および粘膜／非経口複合免疫法
SE9702241D0 (sv) * 1997-06-12 1997-06-12 Astra Ab Vaccine compositions IV
SE9702242D0 (sv) * 1997-06-12 1997-06-12 Astra Ab Vaccine compositions V
US7393529B2 (en) * 1998-04-09 2008-07-01 Idexx Laboratories, Inc. Methods and compositions for inhibiting binding of IgE to a high affinity receptor
SE9801288D0 (sv) * 1998-04-14 1998-04-14 Astra Ab Vaccine delivery system and metod of production
US6841155B1 (en) * 1998-04-30 2005-01-11 Chiron S.R.L. Immunization against and treatment for infection by H. pylori
WO2000049044A1 (en) * 1999-02-19 2000-08-24 Astrazeneca Ab Expression of helicobacter polypeptides in pichia pastoris
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
EP1278768B1 (en) * 2000-04-27 2006-11-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for identifying helicobacter antigens
GB0010371D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
US20020107368A1 (en) * 2000-12-07 2002-08-08 Jing-Hui Tian Helicobacter proteins, gene sequences and uses thereof
ATE495189T1 (de) 2003-08-15 2011-01-15 Univ Florida Die identifikation von polynukleotiden von porphyromonas gingivalis-virulenz zur diagnose, behandlung und beobachtung von periodontalerkrankungen
US7381547B2 (en) * 2004-04-28 2008-06-03 Tzam Diagnostics, Llc Methods and compositions to detect bacteria using multiplex PCR
KR100613924B1 (ko) * 2004-06-23 2006-08-21 현대자동차주식회사 자동차 연료 시스템
WO2007014179A2 (en) * 2005-07-25 2007-02-01 University Of Rochester Method for controlling immunodominance
AU2008279584A1 (en) * 2007-04-27 2009-01-29 Dow Global Technologies Inc. Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles
CN101496898B (zh) * 2009-02-16 2011-06-15 中国人民解放军军事医学科学院生物工程研究所 一种预防和/或治疗幽门螺杆菌感染的疫苗
RU2449805C1 (ru) 2011-01-27 2012-05-10 Общество С Ограниченной Ответственностью "Гармония" Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования
AU2016374289B2 (en) 2015-12-14 2023-08-03 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Helicobacter pylori vaccines
US10577409B2 (en) * 2016-05-26 2020-03-03 Sagabio Co., Ltd. Monoclonal antibody inhibiting immunosuppressive functions of pathogens, antigen-binding fragment thereof, and hybridomas producing such antibody
CN107456578A (zh) * 2016-06-03 2017-12-12 硕英生医股份有限公司 一种关闭病原体的免疫抑制功能的方法及其用途
EP3272354A1 (en) 2016-07-20 2018-01-24 Technische Universität München Agents and methods for the prevention or treatment of h. pylori infections
CN111467368B (zh) * 2020-04-13 2021-05-28 江南大学 含庚糖链的寡糖化合物在制备幽门螺旋杆菌疫苗中的应用
CN113144182B (zh) * 2021-04-22 2023-03-10 成都欧林生物科技股份有限公司 一种幽门螺杆菌口服缓释疫苗及其制备与应用
CN113896775A (zh) * 2021-08-25 2022-01-07 河北医科大学第四医院 幽门螺杆菌特异性免疫原性肽段

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69012318T2 (de) * 1989-03-09 1995-03-09 Praxis Biologics, Inc., Rochester, N.Y. Impfstoffe gegen hämophilus influenzae.
RU2009507C1 (ru) * 1991-06-28 1994-03-15 Российский государственный медицинский университет Способ диагностики пилорического геликобактериоза
US5721349A (en) * 1992-02-26 1998-02-24 Vanderbilt University Vacuolating toxin-deficient H. pylori
MX9301706A (es) * 1992-04-13 1994-05-31 Oravax Inc Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
US5420014A (en) * 1992-04-30 1995-05-30 Auspharm International Ltd. Rapid in vitro test for helicobacter pylori using saliva

Also Published As

Publication number Publication date
AU703331B2 (en) 1999-03-25
AR003125A1 (es) 1998-07-08
KR19990022131A (ko) 1999-03-25
MX9709194A (es) 1998-07-31
EP0828757A1 (en) 1998-03-18
HUP9901546A2 (hu) 1999-08-30
JP3380559B2 (ja) 2003-02-24
NO975490L (no) 1998-01-07
IL122340A0 (en) 1998-04-05
NZ303356A (en) 1999-05-28
CN1191544A (zh) 1998-08-26
TW570925B (en) 2004-01-11
NO975490D0 (no) 1997-11-28
MY119003A (en) 2005-03-31
US20020168726A1 (en) 2002-11-14
CZ357397A3 (cs) 1998-05-13
RU2195463C2 (ru) 2002-12-27
HUP9901546A3 (en) 2003-07-28
TR199701471T1 (xx) 1998-02-21
SK155297A3 (en) 1998-08-05
EE9700306A (xx) 1998-06-15
CA2222797A1 (en) 1996-12-05
BR9608627A (pt) 1999-06-15
US6025164A (en) 2000-02-15
WO1996038475A1 (en) 1996-12-05
AU6020596A (en) 1996-12-18
PL323741A1 (en) 1998-04-14
JPH11507210A (ja) 1999-06-29

Similar Documents

Publication Publication Date Title
EE9700306A (xx) Helicobacter pylori antigeenid ja vaktsiinisegud
NO944475D0 (no) Kombinerte vaksiner omfattende Hepatit B overflateantigen og andre antigener
FI943171L (fi) Ureaasipohjainen rokote Helicobacter-infektiota vastaan
NO20071415L (no) OB-fusjonsproteinpreparater og fremgangsmater
DK0822831T4 (da) Vacciner indeholdende en saponin og en sterol
FI963281A7 (fi) Ureaasipohjainen rokote ja helicobakteeri-infektion hoito
NO985339D0 (no) Humane B-celleantigener og beslektede reagenser
IS4879A (is) Efnablöndur dreifanlegra stórsameinda og aðferðirtil gerðar þeirra og notkunar
NO20014219D0 (no) <Kappa>-agonist-forbindelser og farmasöytiske preparater derav
NO982329D0 (no) Kreftvaksine og fremgangsmÕte for fremstilling derav
DK0729956T3 (da) Benzothi9phenforbindelser, emllemprodukter, præparater og fremgangsmåder
RU98100200A (ru) Антигены helicobacter pylori и вакцинные композиции
DK0765333T3 (da) Quillajasaponinadjuvans og vaccineformulering, der indeholder denne
NO931005D0 (no) Fremgangsmaate og anordning for seismiske undersoekelser
IS5005A (is) Kjarnsýrur og amínósýruraðir er tengjast Helicobacter pylori og bóluefni úr þeim
NO965023D0 (no) Maltitolblanding og fremstilling derav
IS5047A (is) Kjarnsýru- og amínósýruraðir er tengjast Helicobacter pylori og bóluefni úr þeim
PT863991E (pt) Preparacoes antigenicas
DK43489D0 (da) Immunotoksin og fremgangsmaade til dets fremstilling
DK32989D0 (da) Immunoglobulin-konjugater og fremgangsmaade til fremstilling deraf
FI973335A7 (fi) Helicobacter pylori-antigeeni
DK108990D0 (da) Svinedysenteri subenhedsvaccine og fremgangsmaade til fremstilling deraf
EP0770092A4 (en) PROTEIN D'-i (HELICOBARTER PYLORI) LINKED TO NICKEL
FI953257A7 (fi) Rekombinanttinen ihmisen prostaspesifinen antigeeni ja sen käytöt
NO974932D0 (no) Pesticidpreparater og fremgangsmåte for fremstilling derav